In a more benign version of the game (as opposed to the one selling for pennies at the Border’s liquidation sales)…
Would you rather pay 27x 2011 EPS for a company with admitted and continuing inventory issues?
Or 10x for a company known to be filling lost production in Japan, implying at least lower than expected inventory which is already low?
CREE vs RBCN. You figure it out.
Comments are closed.
